Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Role of the Biliary Salts Nuclear Receptor FXR in Hepatitis C Virus Replication

NCT01492998 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT01492998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01492998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Role of the Biliary Salts Nuclear Receptor FXR in Hepatitis C Virus Replication
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2010
Completion date
Not reported
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c